|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2100050699 |
|
最近更新日期: Date of Last Refreshed on: |
2021-11-04 01:03:23 |
|
注册时间: Date of Registration: |
2021-09-02 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
真实临床背景下膝骨关节炎中西医现状调查 |
|
Public title: |
Investigation of traditional Chinese and Western medicine in the real world of knee osteoarthritis |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
真实临床背景下膝骨关节炎中西医现状调查 |
|
Scientific title: |
Investigation traditional Chinese and Western medicine in the real world of knee osteoarthritis |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
ChiMCTR2100005263 |
|
申请注册联系人: |
金晔华 |
研究负责人: |
何东仪 |
|
Applicant: |
Jin Yehua |
Study leader: |
He Dongyi |
|
申请注册联系人电话: Applicant telephone: |
13916697415 |
研究负责人电话:
Study leader's |
15800300800 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
jinyehua1991@163.com |
研究负责人电子邮件: Study leader's E-mail: |
dongyihe@medmail.com.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市长宁区新华路540号 |
研究负责人通讯地址: |
上海市长宁区新华路540号 |
|
Applicant address: |
No. 540 Xinhua Road, Changning District, Shanghai |
Study leader's address: |
No. 540 Xinhua Road, Changning District, Shanghai |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
上海市光华中西医结合医院 |
||
|
Applicant's institution: |
Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine |
||
|
研究负责人所在单位: |
|
||
|
Affiliation of the Leader: |
|
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2021-k-54 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
上海市光华中西医结合医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2021-07-07 00:00:00 | ||
|
伦理委员会联系人: |
朱丹 |
||
|
Contact Name of the ethic committee: |
Zhu Dan |
||
|
伦理委员会联系地址: |
上海市长宁区延安西路1474号 |
||
|
Contact Address of the ethic committee: |
No. 1474, Yan'an West Road, Changning District, Shanghai |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
上海市光华中西医结合医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市长宁区新华路540号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 540 Xinhua Road, Changning District, Shanghai |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
上海市中医专科联盟建设项目(ZY(2018-2020)-FWTX-4017) |
||||||||||||||||||||||
|
Source(s) of funding: |
Shanghai Traditional Chinese Medicine Specialty Alliance Project (ZY(2018-2020)-FWTX-4017) |
||||||||||||||||||||||
|
研究疾病: |
膝骨关节炎 |
||||||||||||||||||||||
|
Target disease: |
Knee osteoarthritis |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
本研究拟开展真实世界背景下膝骨关节炎现状的多中心的调查研究,对临床上膝骨关节炎患者人群进行大规模调研,建立膝骨关节炎的临床实际应用医院登记的研究、质控、数据管理和统计分析平台,采用队列,收集患者资料,分析国内真实世界背景下膝骨关节炎的临床特点、中医证候、治疗情况等内容,以积累临床数据,阐明真实世界背景下的膝骨关节炎现状,为实际临床应用提供可靠数据支持,为未来膝骨关节炎的进一步深入研究奠定临床基础,为中国膝骨关节炎患者获益带来一定的临床价值。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study intends to carry out a multi center investigation on the current situation of knee osteoarthritis in the real world background, conduct a large-scale investigation on the clinical population of knee osteoarthritis patients, and establish a hospital registration research, quality control, data management and statistical analysis platform for the clinical application of knee osteoarthritis.In order to accumulate clinical data, clarify the current situation of knee osteoarthritis in the real world and provide reliable data support for practical clinical application, cohort study was used to collect patient data and analyze the clinical characteristics, TCM syndromes and treatment of knee osteoarthritis in the real world, It will lay a clinical foundation for further study of knee osteoarthritis in the future, and bring certain clinical value for Chinese patients with knee osteoarthritis |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
符合膝骨关节炎的诊断标准(中华医学会骨科学分会关节外科学组2018年版骨关节炎诊疗指南中膝关节骨关节炎的诊断标准)患者方可入组研究。 |
||||||||||||||||||||||
|
Inclusion criteria |
Only patients who meet the diagnostic criteria for knee osteoarthritis (the diagnostic criteria for knee osteoarthritis in the 2018 edition of the osteoarthritis diagnosis and treatment guidelines of the Joint Surgery Group of the Orthopedic Branch of the Chinese Medical Association) can be included in the study. |
||||||||||||||||||||||
|
排除标准: |
不符合膝骨关节炎诊断标准的患者 |
||||||||||||||||||||||
|
Exclusion criteria: |
Patients who do not meet the diagnostic criteria for knee osteoarthritis |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2021-10-01 00:00:00至 To 2023-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2021-10-01 00:00:00 至 To 2023-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
符合诊断即纳入研究 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Included in the study when the diagnosis is met |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
发送电子邮件向研究者申请 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Send an email to the researcher to apply. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
本研究数据管理由本课题组负责,确保数据的真实性,完整性,私密性和可溯源性。由项目负责人或课题组相关成员将信息写入随访表格中,只有具备医疗资格及相关知识的研究者才能填写随访表格。原始数据录入后,做出的任何修改都需要记录,任何已经认可的数据修改,均需要修改人的签名,日期,及修改理由。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
The research group is responsible for the data collection and management of this study to ensure the authenticity, integrity, privacy and traceability of the data. The project leader or relevant members of the research team will write the information into the follow-up questionnaire. Only researchers with medical qualifications and relevant knowledge can fill in the questionnaire. After the original data is entered, any modification made shall be recorded. Any approved data modification shall be signed by the modifier, date and reason for modification. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |